SS-31 25mg

Research Specifications

Sequence:
D-Arg-2',6'-Dmt-Lys-Phe-NH2
CAS:
736992-21-5
Molecular Weight:
639.79 Da
Vial:
25mg lyophilized
Purity:
≥98% HPLC verified
Storage:
−20°C long-term / 4°C up to 4 weeks reconstituted

SS-31 25mg

Elamipretide cardiolipin-binding tetrapeptide

CAS: 736992-21-5

Cardiolipin

Primary target

Szeto 2014

Phase 3

Most advanced stage

Stealth BioTx

25mg

Larger vial

~2.5× the protocol length of 10mg vial

$170.99In Stock
Buy Now
≥98% Purity Verified Free Shipping $200+ HPLC Tested
Phase 3

Phase 3 trials (Stealth BioTherapeutics)

2024 FDA Complete Response Letter for Barth syndrome. Ongoing development in mitochondrial myopathy, LHON, and dry AMD.

Also Known As

ElamipretideBendaviaMTP-131SS-31Szeto-Schiller peptide 31

Prep & Cycle Schedule

BAC Water

5mL

Final Concentration

5 mg/mL

Per Dose

20 mg = 4 mL · 5 mg (exploratory) = 1 mL

Clinical label dose is 40mg/day — this vial covers ~5–6 days at that rate

Published References

  1. 1.
    Szeto HH, Birk AV. Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clinical Pharmacology & Therapeutics (2014) PMID: 24960521

Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.

Price Comparison

SupplierPurityPriceShipping
our verified supplier>98% HPLC$170.99Free over $200
Generic Research SuppliersVaries (often <95%)Similar–HigherVaries
Pharmaceutical (Rx only)Pharmaceutical gradeNot available for researchRx required

SS-31 25mg

$170.99

Buy Now